NEW YORK (CBSNewYork) — Meridian Medical Technologies, makers of Mylan's EpiPen Auto-Injector, have issued a voluntary recall of its EpiPen and EpiPen Jr. injectors. "The potential defect could make ...

* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies' voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products ...

Pro Football Player Adrian Peterson is Calling on Americans to be Ready2Go™ and Learn How to be Aware and Prepared for Anaphylaxis PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Specialty, the fully ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

While EpiPen prescriptions are still increasing, Mylan’s share of the epinephrine auto-injector market fell for the first time in three years, according to research from athenahealth. The analysis is ...

While numerous companies attempted to set foot in the epinephrine auto-injection market, none were able to significantly impact Canonsburg, Pa.-based Mylan’s control of the market. This dominance ...

June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...

Shortly after Cigna announced it would stop covering the name-brand EpiPen, CVS declared it would begin selling a cheaper generic version of the costly epinephrine injector. Earlier in the week, ...

Sanofi claimed Viatris (formerly Mylan) used rebates to pharmacy benefit managers to secure monopoly A 10th Circuit panel said negotiating exclusivity for lower consumer prices was legal (Reuters) - ...

PITTSBURGH, June 23, 2021 /PRNewswire/ — Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan’s favor on the company’s ...